KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Other Non Operating Income (2017 - 2025)

Cardlytics (CDLX) has disclosed Other Non Operating Income for 9 consecutive years, with -$6.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 171.96% year-over-year to -$6.3 million, compared with a TTM value of $15.0 million through Sep 2025, up 254.37%, and an annual FY2024 reading of $13.0 million, changed N/A over the prior year.
  • Other Non Operating Income was -$6.3 million for Q4 2025 at Cardlytics, down from -$1.8 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $10.9 million in Q4 2022 and bottomed at -$8.8 million in Q3 2024.
  • Average Other Non Operating Income over 5 years is -$98947.4, with a median of -$379000.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income surged 25406.98% in 2022, then crashed 2418.47% in 2024.
  • Year by year, Other Non Operating Income stood at -$43000.0 in 2021, then soared by 25406.98% to $10.9 million in 2022, then tumbled by 103.48% to -$379000.0 in 2023, then soared by 2396.83% to $8.7 million in 2024, then tumbled by 171.96% to -$6.3 million in 2025.
  • Business Quant data shows Other Non Operating Income for CDLX at -$6.3 million in Q4 2025, -$1.8 million in Q3 2025, and $5.4 million in Q2 2025.